These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 226043)

  • 21. [Analphalipoproteinemia and cardiovascular risk. Case of Tangier disease].
    Clerc M; Dumon MF; Dubourg L; Jasawant T; Auche Y
    Bull Acad Natl Med; 1986 Jan; 170(1):141-8. PubMed ID: 3527346
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac valvular involvement in Tangier disease.
    Pressly TA; Franklin JO; Alpert MA; Reams GP; Taylor LM
    Am Heart J; 1987 Jan; 113(1):200-2. PubMed ID: 3799433
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiologic aspects of a case of Tangier disease].
    Plancher AC; Maccari S; Tramaloni C; Vigotti G; Giudici GA
    G Clin Med; 1984; 65(3-4):189-97. PubMed ID: 6234195
    [No Abstract]   [Full Text] [Related]  

  • 24. Tangier disease in a black patient: an unusual clinical presentation.
    Lo WD; Sloan HR; Fahey BP; Donat JF; Strobl W; Patsch JR; Gotto AM; Patsch W
    Am J Med; 1990 Jul; 89(1):105-8. PubMed ID: 2164324
    [No Abstract]   [Full Text] [Related]  

  • 25. Mucolipidosis IV: ocular, systemic, and ultrastructural findings.
    Merin S; Livni N; Berman ER; Yatziv S
    Invest Ophthalmol; 1975 Jun; 14(6):437-48. PubMed ID: 166049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tangier-disease (author's transl)].
    Assmann G
    Klin Wochenschr; 1979 Jan; 57(2):53-61. PubMed ID: 216846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial hypoalphalipoproteinemia. Vergani's disease].
    Dioguardi N
    Minerva Med; 1983 Nov; 74(44):2659-64. PubMed ID: 6657116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 'Fish-eye disease' familial condition with massive corneal opacities and hypoalphalipoproteinaemia: clinical, biochemical and genetic features.
    Clerc M; Dumon MF; Sess D; Freneix-Clerc M; Mackness M; Conri C
    Eur J Clin Invest; 1991 Dec; 21(6):616-24. PubMed ID: 1778223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tangier disease. Presentation of a case].
    Salazar M; Ambrosius K; Valencia P
    Bol Med Hosp Infant Mex; 1986 Oct; 43(10):642-6. PubMed ID: 3778628
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tangier disease. A rare thesaurismosis].
    Labbé A; Dechelotte P; Meyer M; Dubray C; Jouanel P
    Presse Med; 1985 May; 14(21):1189-92. PubMed ID: 3158991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemolytic anaemia in analpha-lipoproteinaemia (Tangier disease): morphological, biochemical, and biophysical properties of the red blood cell.
    Reinhart WH; Gössi U; Bütikofer P; Ott P; Sigrist H; Schatzmann HJ; Lutz HU; Straub PW
    Br J Haematol; 1989 Jun; 72(2):272-7. PubMed ID: 2757970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular and Genetic Characteristics Observed in Two Cases of Fish-Eye Disease.
    Ustaoglu M; Solmaz N; Baser B; Kurtulgan HK; Onder F
    Cornea; 2019 Mar; 38(3):379-383. PubMed ID: 30394912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies.
    Gibbels E; Schaefer HE; Runne U; Schröder JM; Haupt WF; Assmann G
    J Neurol; 1985; 232(5):283-94. PubMed ID: 2997405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tangier disease: study of the first case in Spain].
    Leal Luna A; Blanco Vaca F; Gómez Gerique JA; Pérez Gallofré A; Franco Peral M; Fabiani Romero F
    Med Clin (Barc); 1989 Sep; 93(8):301-3. PubMed ID: 2607835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paranodal pathology in Tangier disease with remitting-relapsing multifocal neuropathy.
    Cai Z; Blumbergs PC; Cash K; Rice PJ; Manavis J; Swift J; Ghabriel MN; Thompson PD
    J Clin Neurosci; 2006 May; 13(4):492-7. PubMed ID: 16678735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathy in Tangier disease: A clinicopathologic study and a review of the literature.
    Pietrini V; Rizzuto N; Vergani C; Zen F; Ferro Milone F
    Acta Neurol Scand; 1985 Nov; 72(5):495-505. PubMed ID: 4082916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.